The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Tsai Philip since 2024.
This trader's CIK number is 2026600.
At the time of last reporting, Tsai Philip was the Chief Technology Officer of Immunome Inc.. (stock ticker symbol IMNM).
Also see all insider trading activities at Immunome Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | IMNM | 12,300 | $103,566 | 0 | $0 | 0 | $0 |
| 2024 | IMNM | 21,000 | $198,030 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-24 | IMNM | Buy | 12,300 | 8.42 | 103,566 |
| 2024-11-21 | IMNM | Buy | 21,000 | 9.43 | 198,030 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Tsai Philip (Chief Technology Officer of Immunome Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.